Example question: Bloomberg reported that supply constraints are leading to iPhone shortages. Do Trefis analysts see a meaningful impact on AAPL?
Example comment: Competition will squeeze AMZN's operating margins from 4% to 2% meaning a 10% hit to the stock according to Trefis.
Name (Required)
Email (Required, but never displayed)
* Companies:
Johnson & Johnson Logo
  • commented 8/27/15
  • tags: JNJ MRK PFE
  • Hi Trefis,

    I am still wary of JNJ's long term performance. Undoubtedly the company has been an outperformer and a core holding on most funds and in any retail investors' portfolios. But after reading some stuff about the company, I saw there are ongoing litigations and possible challenges that would surface once Medicare figures out how to reduce its cost in reimbursement of prosthesis devices, and also certain other pharma companies are now getting into biosimilars for remicade that would directly compete and be more affordable-20-30% less-than what is being sold right now in the US market. [ less... ]
    Hi Trefis, I am still wary of JNJ's long term performance. Undoubtedly the company has been an outperformer and a core holding on most funds and in any retail investors' portfolios. But after reading some stuff about the company, I saw there are ongoing litigations and possible challenges that would surface once Medicare figures out how to reduce its cost in reimbursement of prosthesis devices, and also certain other pharma companies are now getting into biosimilars for remicade that would directly compete and be more affordable-20-30% less-than what is being sold right now in the US market.
    Name (Required)
    Email (Required, but never displayed)